Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, United States.
Bioorg Med Chem Lett. 2011 Dec 1;21(23):7210-5. doi: 10.1016/j.bmcl.2011.09.033. Epub 2011 Sep 25.
GalR1 and GalR2 represent unique pharmacological targets for treatment of seizures and epilepsy. A novel series of 2,4,6-triaminopyrimidine derivatives were synthesized and found to have sub-micromolar affinity for GalR2. Optimization of a series of 2,4,6-triaminopyrimidines led to the discovery of several analogs with IC50 values ranging from 0.3 to 1 μM.
GalR1 和 GalR2 是治疗癫痫和癫痫发作的独特药理学靶点。我们合成了一系列新型的 2,4,6-三氨基嘧啶衍生物,并发现它们对 GalR2 具有亚微摩尔亲和力。对一系列 2,4,6-三氨基嘧啶进行优化,发现了几种具有 0.3 至 1 μM 范围内 IC50 值的类似物。